Apellis Pharmaceuticals, Inc. (APLS)

25.11 +0.29 (+1.17%) USD  |  NASDAQ  |  Dec 24, 12:00
More

Apellis Pharmaceuticals Return on Invested Capital (3y Median)

Return on Invested Capital (3y Median) Chart

View Return on Invested Capital (3y Median) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Invested Capital (3y Median) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Invested Capital (3y Median) Range, Past 5 Years

View Return on Invested Capital (3y Median) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Invested Capital (3y Median) Benchmarks

View Return on Invested Capital (3y Median) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
Fulcrum Therapeutics, Inc. Upgrade